Claritev Debt to Equity Ratio 2019-2024 | CTEV
Current and historical debt to equity ratio values for Claritev (CTEV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Claritev debt/equity for the three months ending December 31, 2024 was 310.26.
| Claritev Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $5.07B | $0.08B | 60.30 |
| 2024-09-30 | $5.11B | $0.21B | 24.63 |
| 2024-06-30 | $5.14B | $0.60B | 8.52 |
| 2024-03-31 | $5.20B | $1.17B | 4.44 |
| 2023-12-31 | $5.26B | $1.71B | 3.08 |
| 2023-09-30 | $5.31B | $1.75B | 3.03 |
| 2023-06-30 | $5.37B | $1.77B | 3.04 |
| 2023-03-31 | $5.43B | $1.79B | 3.04 |
| 2022-12-31 | $5.58B | $1.79B | 3.12 |
| 2022-09-30 | $5.76B | $2.44B | 2.36 |
| 2022-06-30 | $5.81B | $2.41B | 2.41 |
| 2022-03-31 | $5.88B | $2.39B | 2.46 |
| 2021-12-31 | $5.88B | $2.35B | 2.51 |
| 2021-09-30 | $5.92B | $2.36B | 2.52 |
| 2021-06-30 | $6.00B | $2.34B | 2.57 |
| 2021-03-31 | $5.98B | $2.38B | 2.52 |
| 2020-12-31 | $5.73B | $2.56B | 2.24 |
| 2020-09-30 | $0.05B | $1.06B | 0.05 |
| 2020-06-30 | $0.04B | $1.07B | 0.04 |
| 2020-03-31 | $0.04B | $1.07B | 0.04 |
| 2019-12-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.435B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.096B | 54.00 |
| Hims & Hers Health (HIMS) | United States | $13.681B | 142.14 |
| Tempus AI (TEM) | United States | $11.156B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.596B | 71.81 |
| IRhythm Technologies (IRTC) | United States | $4.484B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.069B | 11.53 |
| Schrodinger (SDGR) | United States | $1.747B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.691B | 0.00 |
| Phreesia (PHR) | United States | $1.537B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.74 |
| Azenta (AZTA) | United States | $1.233B | 57.32 |
| 10x Genomics (TXG) | United States | $1.115B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 154.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 825.00 |
| Health Catalyst (HCAT) | United States | $0.291B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |